Replicel Sets The Record Straight

[tbtadmin]

Spencer Kobren speaks with VP of Business and Corporate development for Replicel Life Sciences, R. Lee Buckler, to set the record straight and to clear up all of the misinformation about the company and its efforts to move forward with its DSC cell therapy treatment for androgenetic alopecia. It appears that it’s full steam ahead for Replicel and the reasons for some of the delays had nothing to do with the online speculation that has been circulating throughout the hair loss community.